By James Beck ( December 5, 2018, 2:01 PM EST) -- "The Demise of Drug Design Litigation: Death by Federal Preemption" is the intriguing title of the latest law review article written by the "Rabbi of Torts," Prof. Aaron Twerski (we're not making this up — Twerski's Wikipedia page is the fifth result when we just Googled that phrase). Twerski, one of the American Law Institute's reporters for the Restatement (Third) of Torts: Products Liability, has probably spilled as much ink as anyone in making sense of Restatement (Second) of Torts Section 402A, comment k (1965), one of the more opaque parts of the venerable Section 402A....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.